Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
This study is ongoing, but not recruiting participants.
Study NCT00288600   Information provided by Oswaldo Cruz Foundation
First Received: February 6, 2006   Last Updated: October 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperbilirubinemia
Erythroblastosis, Fetal
Additional conditions recognized in this trial
Rh Isoimmunization
More general conditions related to this trial
Blood Group Incompatibility
Fetal Diseases
Hematologic Diseases
Immune System Diseases
Infant, Newborn, Diseases
Pathologic Processes
Pregnancy Complications
Interventions listed in this trial
Intravenous Immunoglobulin
Normal saline solution
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Oswaldo Cruz Foundation
FAPERJ


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services